Anxiety disorder is a common mental disorder. It is necessary to establish a rapid, stable and specific anxiety model to provide a theoretical basis for further research on the pathogenesis of anxiety and drug development. A single intraperitoneal injection of m-chlorophenylpipera-zine (mCPP) (1, 2, 4 mg/kg) was given to male ICR mice to establish an anxiety model, and the effects of mCPP on anxiety behavior, pain, athletic ability, passive avoidance response ability and depressive behavior of male ICR mice were evaluated. A single intraperitoneal injection of mCPP shortened the time in open arms and decreased the percentage of time in open arms of mice in the elevated plus-maze test. mCPP also shortened center zone distance and reduced the number of entries to the central zone in the open field test. Moreover, mCPP reduced head-dip counts and increased the head-dip latency of mice in the hole-board test. After being administrated with a single intraperitoneal injection of mCPP for 24h, the mice showed no significant difference in the entry into the light side and the percentage of time in the light side of the light-dark box test. A single intraperitoneal injection of mCPP had no effects on tail flick latency, rotating time, number of errors and the step-down latency, the immobility time of mice in the tail-flick test, rotarod test, step-down test and TST respectively. In conclusion, we established a rapid and stable anxiety mouse model by single intraperitoneal injection of mCPP.
References
[1]
Calhoon, G.G. and Tye, K.M. (2015) Resolving the Neural Circuits of Anxiety. Nature Neuroscience, 18, 1394-1404. https://doi.org/10.1038/nn.4101
[2]
Kessler, R.C., Chiu, W.T., Dernier, O., Merikangas, K.R. and Walters, E.E. (2005) Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617-627. https://doi.org/10.1001/archpsyc.62.6.617
[3]
Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R. and Walters, E.E. (2005) Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593-602. https://doi.org/10.1001/archpsyc.62.6.593
[4]
Nasca, C., Orlando, R., Marchiafava, M., Boldrini, P., Battaglia, G., Scaccianoce, S., Matrisciano, F., Pittaluga, A. and Nicoletti, F. (2013) Exposure to Predator Odor and Resulting Anxiety Enhances the Expression of the α2δ Subunit of Voltage-Sensitive Calcium Channels in the Amygdala. Journal of Neurochemistry, 125, 649-656. https://doi.org/10.1111/j.1471-4159.2012.07895.x
[5]
Shin, S.Y., Baek, N.J., Han, S.H. and Min, S.S. (2019) Chronic Administration of Ketamine Ameliorates the Anxiety- and Aggressive-Like Behavior in Adolescent Mice Induced by Neonatal Maternal Separation. The Korean Journal of Physiology & Pharmacology, 23, 81-87. https://doi.org/10.4196/kjpp.2019.23.1.81
[6]
Stein, D.J., Vasconcelos, M.F., Albrechet-Souza, L., Cereser, K.M.M. and De Almeida, R.M.M. (2017) Microglial Over-Activation by Social Defeat Stress Contributes to Anxiety- and Depressive-Like Behaviors. Frontiers in Behavioral Neuroscience, 11, Article 207. https://doi.org/10.3389/fnbeh.2017.00207
[7]
Assad, N., Luz, W.L., Santos-Silva, M., Carvalho, T., Moraes, S., Picanco-Diniz, D.L.W., Bahia, C.P., Oliveira Batista, E.J., Da Conceicao Passos, A., Oliveira, K., et al. (2020) Acute Restraint Stress Evokes Anxiety-Like Behavior Mediated by Telencephalic Inactivation and GabAergic Dysfunction in Zebrafish Brains. Scientific Reports, 10, Article No. 5551. https://doi.org/10.1038/s41598-020-62077-w
[8]
Sun, X.L., Zhang, T.Z., Zhao, Y., Cai, E.B., Zhua, H.Y. and Liu, S.L. (2020) Panaxynol Attenuates CUMS-Induced Anxiety and Depressive-Like Behaviors via Regulating Neurotransmitters, Synapses and the HPA Axis in Mice. Food & Function, 11, 1235-1244. https://doi.org/10.1039/C9FO03104A
[9]
Wang, Y., Li, P., Zhang, L., Fu, J., Di, T., Li, N., Meng, Y., Guo, J. and Zhao, J. (2020) Stress Aggravates and Prolongs Imiquimod-Induced Psoriasis-Like Epidermal Hyperplasis and IL-1β/IL-23p40 Production. Journal of Leukocyte Biology, 10, 267-281. https://doi.org/10.1002/JLB.3MA0320-363RR
[10]
Zhang, Z.S., Qiu, Z.K., He, J.L., Liu, X., Chen, J.S. and Wang, Y.L. (2017) Resveratrol Ameliorated the Behavioral Deficits in a Mouse Model of Post-Traumatic Stress Disorder. Pharmacology Biochemistry and Behavior, 161, 68-76. https://doi.org/10.1016/j.pbb.2017.09.004
[11]
Yang, N., Ren, Z., Zheng, J., Feng, L., Li, D., Gao, K., Zhang, L., Liu, Y. and Zuo, P. (2016) 5-(4-Hydroxy-3-Dimethoxybenzylidene)-Rhodanine (RD-1)-Improved Mitochondrial Function Prevents Anxiety- and Depressive-Like States Induced by Chronic Corticosterone Injections in Mice. Neuropharmacology, 105, 587-593. https://doi.org/10.1016/j.neuropharm.2016.02.031
[12]
Mahdi, S., Almosawi, S., Baksh, H., Qareeballa, A., Alsaleh, B., Falamarzi, F., Alrabaani, M., Alkalbani, A. and Kamal, A. (2019) Effect of Chronic Administration and Withdrawal of Caffeine on Motor Function, Cognitive Functions, Anxiety, and the Social Behavior of BLC57 Mice. International Journal of Health Sciences, 13, 10-16.
[13]
Zhang, N., Zhang, L., Feng, L. and Yao, L. (2018) Cananga Odorata Essential Oil Reverses the Anxiety Induced by 1-(3-Chlorophenyl) Piperazine through Regulating the MAPK Pathway and Serotonin System in Mice. Journal of Ethnopharmacology, 219, 23-30. https://doi.org/10.1016/j.jep.2018.03.013
[14]
Nehlig, A., Daval, J.L. and Debry, G. (1992) Caffeine and the Central Nervous System: Mechanisms of Action, Biochemical, Metabolic and Psychostimulant Effects. Brain Research Reviews, 17, 139-170. https://doi.org/10.1016/0165-0173(92)90012-B
[15]
De Rezende, V.B., Rosa, D.V., Comim, C.M., Magno, L.A., Rodrigues, A.L., Vidigal, P., Jeromin, A., Quevedo, J. and Romano-Silva, M.A. (2014) NCS-1 Deficiency Causes Anxiety and Depressive-Like Behavior with Impaired Non-Aversive Memory in Mice. Physiology & Behavior, 130, 91-98. https://doi.org/10.1016/j.physbeh.2014.03.005
[16]
Onodera, T., Sakudo, A., Tsubone, H. and Itohara, S. (2014) Review of Studies That Have Used Knockout Mice to Assess Normal Function of Prion Protein under Immunological or Pathophysiological Stress. Microbiology and Immunology, 58, 361-374. https://doi.org/10.1111/1348-0421.12162
[17]
Mamiya, T., Asanuma, T., Kawai, Y., Hasegawa, Y., Nishimura, A., Kumazawa, T. and Ukai, M. (2006) Effects of Soybean Food Pellets on M-CPP-Induced Anxiety Model of Mice. Biological and Pharmaceutical Bulletin, 29, 1498-1500. https://doi.org/10.1248/bpb.29.1498
[18]
Kurt, M., Bilge, S.S., Kukula, O., Celik, S. and Kesim, Y. (2003) Anxiolytic-Like Profile of Propofol, A General Anesthetic, in the Plus-Maze Test in Mice. Polish Journal of Pharmacology, 55, 973-977.
[19]
Cui, X.Y., Zhao, X., Chu, Q.P., Chen, B.Q. and Zhang, Y.H. (2007) Influence of Diltiazem on the Behavior of Zolpidem-Treated Mice in the Elevated-Plus Maze Test. Journal of Neural Transmission, 114, 155-160. https://doi.org/10.1007/s00702-006-0535-1
[20]
Cornelio, A.M. and Nunes-De-Souza, R.L. (2007) Anxiogenic-Like Effects of MCPP Microinfusions into the Amygdala (but Not Dorsal or Ventral Hippocampus) in Mice Exposed to Elevated Plus-Maze. Behavioural Brain Research, 178, 82-89. https://doi.org/10.1016/j.bbr.2006.12.003
[21]
Yonezawa, A., Yoshizumi, M., Ebiko, M., Ise, S., Watanabe, C., Mizoguchi, H., et al. (2008) Ejaculatory Response Induced by a 5-HT2 Receptor Agonist m-CPP in Rats: Differential Roles of 5-HT2 Receptor Subtypes. Elsevier Pharmacology Biochemistry and Behavior, 88, 367-373. https://doi.org/10.1016/j.pbb.2007.09.009
[22]
Gupta, D., Radhakrishnan, M., Thangaraj, D. and Kurhe, Y. (2015) Pharmacological Evaluation of Novel 5-HT3 Receptor Antagonist, QCM-13 (N-Cyclohexyl-3-Methoxyquinoxalin-2-Carboxamide) as Anti-Anxiety Agent in Behavioral Test Battery. Journal of Pharmacy and Bioallied Sciences, 7, 103-108. https://doi.org/10.4103/0975-7406.154429
[23]
Benjamin, D., Lal, H. and Meyerson, L.R. (1990) The Effects of 5-HT1B Characterizing Agents in the Mouse Elevated Plus-Maze. Life Sciences, 47, 195-203. https://doi.org/10.1016/0024-3205(90)90320-Q
[24]
Mamiya, T., Asanuma, T., Kawai, Y., Hasegawa, Y., Nishimura, A., Kumazawa, T. and Ukai, M. (2006) Effects of Soybean Food Pellets on M-CPP-Induced Anxiety Model of Mice. Biological and Pharmaceutical Bulletin, 29, 1498-1500. https://doi.org/10.1248/bpb.29.1498
[25]
Kahn, R.S. and Wetzler, S. (1991) M-Chlorophenylpiperazine as a Probe of Serotonin Function. Biological Psychiatry, 30, 1139-1166. https://doi.org/10.1016/0006-3223(91)90184-N
[26]
Rurak, A. and Melzacka, M. (1983) Effect of Dosage and Route of Administration of Trazodone on Cerebral Concentration of 1-M-Chlorophenylpiperazine in Rats. Kinetics of Trazodone Biotransformation in Rats. Polish Journal of Pharmacology, 35, 241-247.
[27]
Kreiss, D.S. and De Deurwaerdere, P. (2017) Purposeless Oral Activity Induced by Meta-Chlorophenylpiperazine (M-CPP): Undefined Tic-Like Behaviors? Journal of Neuroscience Methods, 292, 30-36. https://doi.org/10.1016/j.jneumeth.2017.05.007
[28]
Tucci, M.C., Dvorkin-Gheva, A., Johnson, E., Wong, M. and Szechtman, H. (2015) 5-HT2A/C Receptors Do Not Mediate the Attenuation of Compulsive Checking by MCPP in the Quinpirole Sensitization Rat Model of Obsessive-Compulsive Disorder (OCD). Behavioural Brain Research, 279, 211-217. https://doi.org/10.1016/j.bbr.2014.11.017
[29]
Khaliq, S., Haider, S., Saleem, S., Memon, Z. and Haleem, D.J. (2012) Influence of Serotonergic 5-HT2C Receptor Antagonist Mesulergine in the Reversal of Memory Deficits Induced by MCPP. Journal of College of Physicians and Surgeons Pakistan, 22, 75-79.
[30]
Charney, D.S., Woods, S.W., Goodman, W.K. and Heninger, G.R. (1987) Serotonin Function in Anxiety. II. Effects of the Serotonin Agonist MCPP in Panic Disorder Patients and Healthy Subjects. Psychopharmacology, 92, 14-24. https://doi.org/10.1007/BF00215473
[31]
Wood, M.D. (2003) Therapeutic Potential of 5-HT2C Receptor Antagonists in the Treatment of Anxiety Disorders. Current Drug Targets—CNS & Neurological Disorders, 2, 383-387. https://doi.org/10.2174/1568007033482698
[32]
Campbell, B.M. and Merchant, K.M. (2003) Serotonin 2C Receptors within the Basolateral Amygdala Induce Acute Fear-Like Responses in an Open-Field Environment. Brain Research, 993, 1-9. https://doi.org/10.1016/S0006-8993(03)03384-5
[33]
Fiorella, D., Helsley, S., Rabin, R.A. and Winter, J.C. (1995) 5-HT2C Receptor-Mediated Phosphoinositide Turnover and the Stimulus Effects of M-Chlorophenylpiperazine. Psychopharmacology, 122, 237-243. https://doi.org/10.1007/BF02246545
[34]
Overstreet, D.H., Knapp, D.J., Breese, G.R. and Diamond, I. (2009) A Selective ALDH-2 Inhibitor Reduces Anxiety in Rats. Pharmacology Biochemistry and Behavior, 94, 255-261. https://doi.org/10.1016/j.pbb.2009.09.004
[35]
Fox, J.H., Hammack, S.E. and Falls, W.A. (2008) Exercise Is Associated with Reduction in the Anxiogenic Effect of MCPP on Acoustic Startle. Behavioral Neuroscience, 122, 943-948. https://doi.org/10.1037/0735-7044.122.4.943
[36]
Takamatsu, H., Noda, A., Murakami, Y., Tatsumi, M., Ichise, R. and Nishimura, S. (2003) A PET Study after Treatment with an Anxiety-Provoking Agent, M-Chlorophenyl-Piperazine, in Conscious Rhesus Monkeys. Journal of Nuclear Medicine, 44, 1516-1521.
[37]
Jones, N., Duxon, M.S. and King, S.M. (2002) Ethopharmacological Analysis of the Unstable Elevated Exposed plus Maze, A Novel Model of Extreme Anxiety: Predictive Validity and Sensitivity to Anxiogenic Agents. Psychopharmacology, 161, 314-323. https://doi.org/10.1007/s00213-002-1029-y
